Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Foundation Medicine, Inc. (NASDAQ: FMI).

Full DD Report for FMI

You must become a subscriber to view this report.


Recent News from (NASDAQ: FMI)

Guardant Health on deck for IPO
Redwood City, CA-based Guardant Health ( GH ) has filed a prospectus for a $100M IPO. More news on: Guardant Health, TrovaGene, Inc., Roche Holding Ltd ADR, Healthcare stocks news, IPOs, Read more ...
Source: SeekingAlpha
Date: September, 06 2018 10:55
Your Daily Pharma Scoop: Foundation Promising, Paratek Moves Up, Ovid Down
Stocks in News: FMI, PRTK Foundation Medicine test helps predict response to Roche's Tecentriq in lung cancer patients Discussion : Foundation Medicine’s ( FMI ) announced a positive outcome of its bTMB assay. In a recent publication in Nature Medicine, a retrospective analysis...
Source: SeekingAlpha
Date: August, 08 2018 06:10
Foundation Medicine test helps predict response to Roche's Tecentriq in lung cancer patients
Foundation Medicine ( FMI ) announces that a retrospective analysis of more than 1,000 samples from NSCLC patients who participated in Roche ( OTCQX:RHHBY -0.9% ) unit Genentech's POPLAR and OAK studies showed that the use of its blood tumor mutational burden (bTMB) assay would have help...
Source: SeekingAlpha
Date: August, 06 2018 15:37
Foundation Medicine Publishes New Data in Nature Medicine Supporting Blood Tumor Mutational Burden (bTMB) as a Novel Predictor of Response to Cancer Immunotherapy
-- New publication details Foundation Medicine’s assay’s ability to measure bTMB and to identify patients who may benefit from anti-PD-L1 therapy -- Foundation Medicine , today announced the publication of the results of a large study demonstrating that its novel, in...
Source: Business Wire
Date: August, 06 2018 12:00
New Research: Key Drivers of Growth for Cadence Design, Agenus, Foundation Medicine, Honeywell International, NeoPhotonics, and Citrix - Factors of Influence, Major Initiatives and Sustained Production
NEW YORK, July 27, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Cadence Design Systems, Inc. (NASDAQ:CDNS), Agenus Inc. (NASDAQ:AGEN), Fo...
Source: GlobeNewswire
Date: July, 27 2018 07:45
Breakfast Technical Briefing on TrovaGene and Three Other Additional Medical Research Stocks
Stock Research Monitor: FMI, NEO, and STIM LONDON, UK / ACCESSWIRE / July 27, 2018 / If you want a free Stock Review on TROV sign up now at www.wallstequities.com/registration . WallStEquities.com draws investors' attention to the Medical Laboratories and Research category, which inclu...
Source: ACCESSWIRE IA
Date: July, 27 2018 07:45
Foundation Medicine and Guardant Health Agree to Settle Patent Infringement Lawsuit
Foundation Medicine, Inc. (NASDAQ:FMI) and Guardant Health, Inc . announced an agreement to settle a patent infringement lawsuit brought by Foundation Medicine against Guardant concerning U.S. Patent No. 9,340,830. Under the terms of the settlement, the lawsuit and counterclaims, as well ...
Source: Business Wire
Date: July, 18 2018 16:00
FOUNDATION MEDICINE, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout
Rigrodsky & Long, P.A.: Do you own shares of Foundation Medicine, Inc. (NASDAQ GS: FMI )? Did you purchase any of your shares prior to June 19, 2018? Do you think the proposed buyout is fair? Do you want to discuss your rights? Rigrodsky & Long, ...
Source: Business Wire
Date: June, 20 2018 13:20
Today's Research Reports on Stocks to Watch: Foundation Medicine and Solid Biosciences
NEW YORK, NY / ACCESSWIRE / June 20, 2018 / Shares of Foundation Medicine exploded on Tuesday after announcing that it has entered into a definitive merger agreement for Roche to acquire the outstanding shares of FMI`s common stock not already owned by Roche and its affiliates at a price of ...
Source: ACCESSWIRE IA
Date: June, 20 2018 08:00
WeissLaw LLP: Foundation Medicine, Inc. Acquisition May Not Be In The Best Interest of FMI Shareholders
NEW YORK , June 19, 2018 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Foundation Medicine, Inc. ("FMI" or the "Company") (NASDAQ: FMI) in connection with the proposed acquisition of the Comp...
Source: PR Newswire
Date: June, 19 2018 18:18

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-1780.5079.7581.0078.0599198,062
2017-05-1635.6536.0036.0035.375171,781
2017-05-1535.4035.5535.8033.95453,847
2017-05-1233.0033.2034.325332.90190,943
2017-05-1134.1532.9534.51632.50325,837

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-07-3042,56288,85247.9021Short
2018-07-2729,05872,64340.0011Short
2018-07-2640,435126,90331.8629Cover
2018-07-2595,259138,08668.9853Short
2018-07-2446,558193,86724.0154Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on FMI.


About Foundation Medicine, Inc. (NASDAQ: FMI)

Logo for Foundation Medicine, Inc. (NASDAQ: FMI)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: FMI)

      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: May, 02 2018
      Quarterly report with a continuing view of a company's financial position
      Filing Type: 10-QFiling Source: edgar
      Filing Date: May, 02 2018
      Official notification to shareholders of matters to be brought to a vote (Proxy)
      Filing Type: DEF 14AFiling Source: edgar
      Filing Date: April, 27 2018
      Additional proxy soliciting materials - definitive
      Filing Type: DEFA14AFiling Source: edgar
      Filing Date: April, 27 2018
      Amendment to a previously filed Form 4
      Filing Type: 4/AFiling Source: edgar
      Filing Date: April, 03 2018
      Filing Type: CT ORDERFiling Source: edgar
      Filing Date: April, 02 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: March, 19 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: March, 07 2018
      Annual report with a comprehensive overview of the company
      Filing Type: 10-KFiling Source: edgar
      Filing Date: March, 07 2018
      Securities offered to employees under employee benefit plans
      Filing Type: S-8Filing Source: edgar
      Filing Date: March, 07 2018

       

       


      Daily Technical Chart for (NASDAQ: FMI)

      Daily Technical Chart for (NASDAQ: FMI)


      Stay tuned for daily updates and more on (NASDAQ: FMI)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: FMI)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      DD Report
      @DDReports

       

       


      Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in FMI is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of FMI and does not buy, sell, or trade any shares of FMI. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/